OArt+ 120

1 ml of the product contains 25 mg of sodium hyaluronate with fermentative origin, low phosphate tampon (sterile, isotonic, apyrogen, pH 7.2), and water for injection.

OArt+ 120 is injected into the knee joint to relieve pain and improve articular mobility associated with degenerative and trauma knee lesions.

The product should not be used for patients

- with a known hypersensitivity reaction to any of the components of the product

- with septic arthritis

- with infections of the skin or dermatological diseases at the injection side

- given coagulation inhibitors

Since septic arthritis is a serious side effect, please observe all usual precautions as for surgical interventions.

The product should be injected into the articulation. Intra-vascular or intra-tissular injection should be avoided.

Since no clinical data are available on the use of hyaluronic acid in children or pregnant woman, these patients should not be treated.

If packaging is damaged, the product should not be used.

The product has to be used before the expiry date indicated on the packaging.

Read carefully the instructions in the leafleat (FIU) or on the packaging, and ask your doctor or pharmacist for advice.

Some local transient reactions may occur after intra-articular injection, such as redness, swelling, heat and pain. 

No known incompatibility with other intra-articular injectable products has been reported up to now.

The product must not be used in association with quaternary ammonium compounds.

The product must not be resterilised or reuse because this could lead to a risk of infection and/or cross-infection and/or malfunction of the product.

The syringe is prefilled. The Luer lock closure is removed and a suitable sharp edged tip sterile needle is screwed on the Luer lock. Use of a single

use needle is recommended.

Remove air bubbles from the syringe before injection.

The skin is disinfected with local antiseptic.

The product is injected in the joint, once a week, 1-5 times.

In the case of intra-articular swelling, fluid should be removed by aspiration before the hyaluronic acid injection.

The prefilled synringe of 1 ml is the volume adapted for small joints.

The prefilled synringe of 2 ml is the volume adapted for the knee, hip, shoulder and ankle.

The prefilled syringe of 4.8 ml is only adapted for the knee joint.

The recommended treatment regimen with the mono dose of 4.8 ml for the knee is one injection, which may be repeated 6 months later based on the clinical experience and the pain relief obtained by the patient.

Exclusively use by medical doctors.

The synovial fluid contains physiologically hyaluronic acid which is responsible for viscoelastic properties allowing, through lubricant properties, painless joint movements. It also participates to the nutrition of the cartilage.

Intra-articular supplementation of the synovial fluid by hyaluronic acid injections helps restoring the viscoelastic properties of the synovial fluid.